The Ro/SSA antigen consists of two different proteins: the 60-kDa Ro protein and the 52-kDa Ro protein (also known as Ro52 or TRIM21). These antigens are often targeted in various autoimmune diseases, including systemic lupus erythematosus (SLE) and Sjögren's syndrome. The expression of Ro/SSA can be influenced by various factors, but direct chemical inducers specifically targeting Ro/SSA expression are not well-established in the literature. The 52 kDa Ro/SSA protein, often simply referred to as Ro52 or SSA, is a cytoplasmic and nuclear protein recognized for its involvement in cellular processes like RNA metabolism, regulation of inflammation, and apoptosis. This protein is a member of the E3 ubiquitin ligase family, which means it plays a role in the ubiquitination process, a post-translational modification pathway that targets proteins for degradation or modulates their function. Ro52's ability to ubiquitinate specific target proteins allows it to regulate various cellular pathways and maintain cellular homeostasis. Interestingly, Ro52 has garnered attention in the immunological context, as autoantibodies against this protein are found in certain autoimmune diseases, indicating its importance in immune regulation.
Activators of the 52 kDa Ro/SSA protein are molecules or compounds that enhance the activity or expression of Ro52. These activators can function by amplifying the protein's inherent E3 ubiquitin ligase activity, by stabilizing its structure, or by boosting its expression at the transcriptional or translational levels. The presence of Ro52 activators can lead to an altered ubiquitination landscape within the cell, impacting the stability or function of various target proteins. Gaining insights into the nuances of 52 kDa Ro/SSA activators provides a deeper understanding of the ubiquitination process and its implications for cellular function and regulation. As scientific exploration continues into the vast world of intracellular proteins and their modulators, the role and significance of Ro52 and its activators stand out, underscoring the intricate web of protein interactions and modifications that shape cellular behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Antimalarial suggested compound may modulate immune response. | ||||||
1-Hydrazinophthalazine Hydrochloride | 304-20-1 | sc-206167 | 10 g | $280.00 | ||
1-Hydrazinophthalazine Hydrochloride likely induces Ro/SSA expression through indirect immunomodulatory and epigenetic effects that modify the activity, phosphorylation or recruitment of Ro/SSA transcriptional control proteins. | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
An antiarrhythmic that can induce lupus-like syndrome. | ||||||
L-α-Methyl-DOPA · sesquihydrate | 41372-08-1 | sc-204788 | 1 g | $23.00 | ||
An antihypertensive that can induce lupus-like syndrome in some individuals. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine could induce Ro/SSA expression via modulation of JAK/STAT, MAPK and other intracellular signaling cascades governing Ro/SSA transcriptional control. | ||||||
Isoflurane | 26675-46-7 | sc-470926 sc-470926A | 5 g 25 g | $69.00 $219.00 | 7 | |
An inhalational anesthetic that in rare reports of association with autoimmune disorders. | ||||||
Penicillamine | 52-67-5 | sc-205795 sc-205795A | 1 g 5 g | $46.00 $96.00 | ||
Used in metal poisoning and rheumatoid arthritis, Penicillamine is known to induce lupus-like syndrome. | ||||||